Syngene International Limited Share Price
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 404.65 INR | +2.94% |
|
+3.46% | -37.84% |
| Capitalization | 16TCr 173.21Cr 147.55Cr 136.56Cr 128.58Cr 239.5Cr 244.4Cr 1.6TCr 626.82Cr 7.74TCr 650Cr 636.22Cr 28TCr | P/E ratio 2026 * |
51.1x | P/E ratio 2027 * | 35.1x |
|---|---|---|---|---|---|
| Enterprise value | 15TCr 161.87Cr 137.89Cr 127.61Cr 120.16Cr 223.82Cr 228.4Cr 1.5TCr 585.78Cr 7.23TCr 607.44Cr 594.57Cr 26TCr | EV / Sales 2026 * |
4.08x | EV / Sales 2027 * | 3.51x |
| Free-Float |
44.57% | Yield 2026 * |
0.25% | Yield 2027 * | 0.33% |
Last Transcript: Syngene International Limited
| 1 day | +2.94% | ||
| 1 week | +3.46% | ||
| Current month | +3.78% | ||
| 1 month | -0.86% | ||
| 3 months | -35.45% | ||
| 6 months | -37.87% | ||
| Current year | -37.84% |
| 1 week | 380 |  | 411.8 |
| 1 month | 380 | | 428 |
| Current year | 380 | | 678.95 |
| 1 year | 380 | | 754.85 |
| 3 years | 380 | | 960.6 |
| 5 years | 380 | | 960.6 |
| 10 years | 177.45 | | 960.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Bains
CEO | Chief Executive Officer | 67 | 15/02/2015 |
Yogesh Chethan
CMP | Compliance Officer | - | 23/07/2025 |
Jayashree Aiyar
CTO | Chief Tech/Sci/R&D Officer | - | 23/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 01/04/2020 | |
| Director/Board Member | 64 | 08/08/2000 | |
| Director/Board Member | 69 | 31/07/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.94% | +3.46% | -42.34% | -33.79% | 173.21Cr | |
| +1.74% | +0.55% | -1.64% | -9.59% | 4.56TCr | |
| -1.20% | -0.36% | +34.42% | +22.90% | 3.43TCr | |
| -0.89% | +2.25% | +28.92% | +27.68% | 2.95TCr | |
| -0.97% | -3.42% | +14.97% | -16.20% | 2.81TCr | |
| +0.22% | -2.71% | +169.96% | +361.83% | 1.91TCr | |
| -1.01% | +4.38% | +58.47% | +198.43% | 1.48TCr | |
| +2.31% | -6.43% | +2,918.75% | +3,811.51% | 1.43TCr | |
| -1.59% | -0.97% | +65.77% | +157.65% | 1.41TCr | |
| +0.25% | -4.10% | +35.07% | +2.59% | 1.33TCr | |
| Average | +0.18% | -0.76% | +328.24% | +452.30% | 2.15TCr | |
| Weighted average by Cap. | -0.03% | -0.77% | +230.09% | +312.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.69TCr 40Cr 34Cr 31Cr 29Cr 55Cr 56Cr 367.28Cr 143.71Cr 1.77TCr 149.02Cr 145.86Cr 6.32TCr | 4.19TCr 45Cr 38Cr 36Cr 33Cr 62Cr 64Cr 416.57Cr 163Cr 2.01TCr 169.02Cr 165.44Cr 7.17TCr |
| Net income | 290.46Cr 3.12Cr 2.66Cr 2.46Cr 2.32Cr 4.32Cr 4.41Cr 29Cr 11Cr 139.48Cr 12Cr 11Cr 496.97Cr | 428.56Cr 4.61Cr 3.93Cr 3.63Cr 3.42Cr 6.37Cr 6.5Cr 43Cr 17Cr 205.8Cr 17Cr 17Cr 733.25Cr |
| Net Debt | -1.05TCr -11Cr -9.66Cr -8.94Cr -8.42Cr -16Cr -16Cr -104.89Cr -41Cr -506.5Cr -43Cr -42Cr -1.8TCr | -1.42TCr -15Cr -13Cr -12Cr -11Cr -21Cr -21Cr -140.77Cr -55Cr -679.78Cr -57Cr -56Cr -2.42TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | 404.65 ₹ | +2.94% | 25,67,574 |
| 09/26/09 | 393.10 ₹ | -1.49% | 9,36,022 |
| 08/26/08 | 399.05 ₹ | +2.08% | 17,58,813 |
| 07/26/07 | 390.90 ₹ | -2.13% | 15,05,794 |
| 06/26/06 | 399.40 ₹ | +2.12% | 9,35,572 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SYNGENE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition